Regulating Cathelicidin Expression for Disease Therapy
Regulating Cathelicidin Expression for Disease Therapy
批准号:
8049149
负责人:
Adrian Friedrich Gombart
金额:
$35.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-15 至 2013-03-31
关键词:
AchievementAntibiotic ResistanceAtopic DermatitisAutomobile DrivingBacteriaBindingBiologicalCCAAT-Enhancer-Binding ProteinsCREB1 geneCebidaeCholecalciferolClinicalDefensinsDevelopmentDiseaseEpithelialEpithelial CellsFamilyGene ExpressionGene Expression RegulationGenesGeneticGenetic TranscriptionGoalsHealthHematopoieticHost DefenseHumanImmuneIn VitroInfectionInflammationInvestigationKnowledgeLeadMammalsMediatingMicrobeMolecularMyelogenousMyeloid CellsPharmaceutical PreparationsPrimatesProcessProsimiiRegulationResearchRetinoidsSepsisSignal PathwaySteroidsTestingTherapeuticTherapeutic UsesThyroid Hormone ReceptorTissuesTranscriptional RegulationTransgenic MiceVitamin DVitaminsactivating transcription factorantimicrobialantimicrobial peptideantimicrobial peptide LL-37cathelicidincell typedriving forcehuman diseasein vivoin vivo Modelinsightinterestmicrobialmouse modelneutrophilnovelpathogenpromoterresponsesmall moleculetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Infections by antibiotic resistant bacteria and the potential for sepsis are a major health concern. Antimicrobial peptides (AMPs) like cathelicidins (CAMP) and defensins are generating considerable interest for therapeutic use as potential bactericidals, anti-LPS drugs and modulators of inflammation, and other potential uses. However, the mechanisms governing CAMP expression are largely unknown. The central hypothesis driving the proposed research is that transcription factors (TFs) from the CCAAT/enhancer binding protein (C/EBP), ETS/PU.1, CREB/ATF and the steroid/thyroid hormone receptor families control constitutive and inducible expression of CAMP in hematopoietic and epithelial tissues. We propose an investigation directed towards achieving 3 Specific Aims: [1] Identify the TFs in myeloid and epithelial cells that regulate CAMP gene transcription; [2a] Determine extent of vitamin DS-mediated induction of CAMP in various human cell types and atopic dermatitis; [2b] Identify mechanism of synergistic activation of human CAMP gene expression by retinoids and vitamin D3; [2c] Discover novel small molecules that regulate CAMP gene expression; [3] Elucidate the biological importance and potential therapeutic benefits of vitamin D3 regulation of CAMP gene expression. Specific Aims 1 and 2 will generate a comprehensive assessment of the transcriptional regulation of the CAMP gene in the myeloid and epithelial compartments and identify additional compounds that either alone or in combination with vitamin D3 may prove therapeutically useful. Specific Aim 3 will characterize the evolutionary and biological importance of antimicrobial gene regulation by vitamin D and will use parallel in vitro and in vivo mouse models that exploit a powerful genetic approach to critically examine how vitamin D3 regulates expression of CAMP in response to microbial invasion or challenge with pathogen-derived molecules. Achievement of these specific aims will provide a comprehensive knowledge of the transcriptional regulation of the CAMP gene and demonstrate the biological importance of vitamin D3-mediated regulation of antimicrobial peptides. This knowledge will lead to the development of approaches for extrinsically manipulating endogenous CAMP expression for systemic and localized therapeutic benefit of human diseases.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.2217/fmb.09.87
发表时间:
2009-11
期刊:
Future microbiology
影响因子:
3.1
作者:
[Gombart AF]
通讯作者:
Gombart AF
DOI:
10.1086/596314
发表时间:
2009-02-15
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
[Gombart AF, Bhan I, Borregaard N, Tamez H, Camargo CA Jr, Koeffler HP, Thadhani R]
通讯作者:
Thadhani R
DOI:
10.1007/s00394-012-0415-4
发表时间:
2012-12
期刊:
European journal of nutrition
影响因子:
5
作者:
[Campbell Y, Fantacone ML, Gombart AF]
通讯作者:
Gombart AF
DOI:
10.1016/j.jsbmb.2014.02.004
发表时间:
2014-09
期刊:
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
影响因子:
4.1
作者:
[Lowry, Malcolm B., Guo, Chunxiao, Borregaard, Niels, Gombart, Adrian F.]
通讯作者:
Gombart, Adrian F.
DOI:
10.1186/1471-2164-10-321
发表时间:
2009-07-16
期刊:
BMC genomics
影响因子:
4.4
作者:
[Gombart AF, Saito T, Koeffler HP]
通讯作者:
Koeffler HP
共 6 条
Vitamin D, Xanthohumol and Nuclear Receptors: Targeting Immunity, Microbiota and
-
批准号:9150689
-
项目类别:
-
资助金额:$51.97万
-
财政年份:2015
-
负责人:Adrian Friedrich Gombart
-
依托单位:
Vitamin D, Xanthohumol and Nuclear Receptors: Targeting Immunity, Microbiota and
-
批准号:9332325
-
项目类别:
-
资助金额:$54.18万
-
财政年份:2015
-
负责人:Adrian Friedrich Gombart
-
依托单位:
Vitamin D, Xanthohumol and Nuclear Receptors: Targeting Immunity, Microbiota and
-
批准号:9759772
-
项目类别:
-
资助金额:$53.15万
-
财政年份:2015
-
负责人:Adrian Friedrich Gombart
-
依托单位:
Regulating Cathelicidin Expression for Disease Therapy
-
批准号:8093622
-
项目类别:
-
资助金额:$20.76万
-
财政年份:2010
-
负责人:Adrian Friedrich Gombart
-
依托单位:
Regulating Cathelicidin Expression for Disease Therapy
-
批准号:8072929
-
项目类别:
-
资助金额:$1.84万
-
财政年份:2010
-
负责人:Adrian Friedrich Gombart
-
依托单位:
Regulating Cathelicidin Expression for Disease Therapy
-
批准号:7700943
-
项目类别:
-
资助金额:$26.45万
-
财政年份:2007
-
负责人:Adrian Friedrich Gombart
-
依托单位:
Regulating Cathelicidin Expression for Disease Therapy
-
批准号:7587978
-
项目类别:
-
资助金额:$35.86万
-
财政年份:2007
-
负责人:Adrian Friedrich Gombart
-
依托单位:
Regulating Cathelicidin Expression for Disease Therapy
-
批准号:7394988
-
项目类别:
-
资助金额:$10.23万
-
财政年份:2007
-
负责人:Adrian Friedrich Gombart
-
依托单位:
Regulating Cathelicidin Expression for Disease Therapy
-
批准号:7259581
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2007
-
负责人:Adrian Friedrich Gombart
-
依托单位:
Regulating Cathelicidin Expression for Disease Therapy
-
批准号:7786268
-
项目类别:
-
资助金额:$35.5万
-
财政年份:2007
-
负责人:Adrian Friedrich Gombart
-
依托单位:
海外基金